186 related articles for article (PubMed ID: 29221216)
21. [Levofloxacin-based triple therapy versus bismuth-based quadruple therapy in the treatment of
Zhang M; Chen CY; Wang XT; Lyu B
Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):368-374. PubMed ID: 28460509
[No Abstract] [Full Text] [Related]
22. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
[TBL] [Abstract][Full Text] [Related]
23. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?
Yoon H; Lee DH; Kim N; Park YS; Shin CM; Kang KK; Oh DH; Jang DK; Chung JW
J Gastroenterol Hepatol; 2013 Dec; 28(12):1801-9. PubMed ID: 24118110
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study.
Chotivitayatarakorn P; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2017 Oct; 18(10):2839-2843. PubMed ID: 29072432
[TBL] [Abstract][Full Text] [Related]
26. Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
Tongtawee T; Dechsukhum C; Leeanansaksiri W; Kaewpitoon S; Kaewpitoon N; Loyd RA; Matrakool L; Panpimanmas S
Asian Pac J Cancer Prev; 2015; 16(12):4885-90. PubMed ID: 26163609
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.
Yu M; Zhang R; Ni P; Chen S; Duan G
PLoS One; 2019; 14(10):e0223309. PubMed ID: 31577828
[TBL] [Abstract][Full Text] [Related]
28. Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis.
Lu C; Sang J; He H; Wan X; Lin Y; Li L; Li Y; Yu C
Sci Rep; 2016 Mar; 6():23522. PubMed ID: 26997149
[TBL] [Abstract][Full Text] [Related]
29. Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy?
Dajani AI; Abu Hammour AM; Yang DH; Chung PC; Nounou MA; Yuan KY; Zakaria MA; Schi HS
Saudi J Gastroenterol; 2013; 19(3):113-20. PubMed ID: 23680708
[TBL] [Abstract][Full Text] [Related]
30. Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.
Hayes SR; Vargas AJ
Explore (NY); 2016; 12(6):463-466. PubMed ID: 27688016
[TBL] [Abstract][Full Text] [Related]
31. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
[TBL] [Abstract][Full Text] [Related]
32. Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
Çekin AH; Şahintürk Y; Akbay Harmandar F; Uyar S; Yolcular BO; Çekin Y
Turk J Gastroenterol; 2017 Jan; 28(1):3-11. PubMed ID: 28007678
[TBL] [Abstract][Full Text] [Related]
33. Probiotics improve efficacy and tolerability of triple therapy to eradicate Helicobacter pylori: a meta-analysis of randomized controlled trials.
Gong Y; Li Y; Sun Q
Int J Clin Exp Med; 2015; 8(4):6530-43. PubMed ID: 26131283
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection.
Du YQ; Su T; Fan JG; Lu YX; Zheng P; Li XH; Guo CY; Xu P; Gong YF; Li ZS
World J Gastroenterol; 2012 Nov; 18(43):6302-7. PubMed ID: 23180952
[TBL] [Abstract][Full Text] [Related]
35. Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.
Li Y; Huang X; Yao L; Shi R; Zhang G
Wien Klin Wochenschr; 2010 Jul; 122(13-14):413-22. PubMed ID: 20628905
[TBL] [Abstract][Full Text] [Related]
36. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis: sequential therapy for Helicobacter pylori eradication in children.
Horvath A; Dziechciarz P; Szajewska H
Aliment Pharmacol Ther; 2012 Sep; 36(6):534-41. PubMed ID: 22827718
[TBL] [Abstract][Full Text] [Related]
38. Sequential Therapy is Superior to Triple Therapy for Helicobacter pylori Infection in Children: A Meta-Analysis.
Huang Y; Zhan X
Indian J Pediatr; 2016 Apr; 83(4):307-15. PubMed ID: 26381545
[TBL] [Abstract][Full Text] [Related]
39. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events.
McFarland LV; Huang Y; Wang L; Malfertheiner P
United European Gastroenterol J; 2016 Aug; 4(4):546-61. PubMed ID: 27536365
[TBL] [Abstract][Full Text] [Related]
40. Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy.
Shimbo I; Yamaguchi T; Odaka T; Nakajima K; Koide A; Koyama H; Saisho H
World J Gastroenterol; 2005 Dec; 11(47):7520-4. PubMed ID: 16437727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
